Acurx Pharmaceuticals director Joseph C. Scodari retires from board effective Nov. 13

ACXP•2026-11-13

Acurx Pharmaceuticals director Joseph C. Scodari gave notice on Nov. 12, 2026, that he would retire from the board effective Nov. 13 and serve as a corporate advisor.

Acurx Pharmaceuticals director Joseph C. Scodari retires from board effective Nov. 13

1. Board retirement

Related News

Soros Fund Management cuts Nvidia stake, exits Uber and KKR

TKO Worldwide issues $1 billion in 6.5% senior secured notes due 2031

Natural Alternatives' Q1 revenue falls on private-label sales drop

Sources

Acurx Pharmaceuticals director Joseph C. Scodari retires from board effective Nov. 13

S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares

Avita Medical issues 267,533 shares through cashless warrant exercises